Colorectal Cancer New Reference: Encorafenib, Cetuximab with FOLFOX for bRAF Mutated Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2025-06-02
Colorectal Cancer New Reference: Neoadjuvant FOLFOX + Panitumumab for Colon Cancer Ulas D. Bayraktar, MD 2025-05-05
Colorectal Cancer New Reference: Neoadjuvant Dostarlimab for dMMR Tumors Ulas D. Bayraktar, MD 2025-05-04
Colorectal Cancer New Reference: Encorafenib, Cetuximab, Chemotherapy in bRAF Mutant Colorectal Cancer Ulas D. Bayraktar, MD 2025-03-31
Colorectal Cancer New Protocol: Ipilimumab + Nivolumab for MSI-H Colorectal Cancer Ulas D. Bayraktar, MD 2025-01-31
Colorectal Cancer New Indication: Sotorasib with Panitumumab in kRAS G12C Mutated Colorectal Cancer Ulas D. Bayraktar, MD 2023-11-20
Colorectal Cancer New Protocol: Trifluridine-Tipiracil and Panitumumab for Refractory RAS WT Colorectal Cancer Ulas D. Bayraktar, MD 2023-09-23
Colorectal Cancer New Indication: Avelumab for MSI-High Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-08-20
Colorectal Cancer New Protocl: Trifluridine-Tipiracil and Bevacizumab in Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-05-20
Colorectal Cancer New Drug: Adagrasib with/without Cetuximab in kRAS G12C Mutant Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
